| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.28 | 1e-14 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-12 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-11 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.22 | 4e-11 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.17 | 9e-09 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-08 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-08 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-08 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |